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Abstract
Analogous to rapid ventricular pacing, frequent ventricular premature complexes (VPCs) may
predispose over time to cardiomyopathy and subsequent heart failure (HF). We examined the
association of frequent VPCs with HF incidence in a population-based cohort, free of HF and
coronary heart disease (CHD) at baseline. At study baseline (1987-89), at least one VPC on a 2-
minute rhythm ECG strip was seen in 5.5% (739/13486) of the middle aged (45-64 years old at
baseline), white and African-American, men and women of the ARIC cohort. Incident HF was
defined as the first appearance of ICD code ‘428.x’ in hospital discharge record or death certificate
through 2005. Over an average follow up of 15.6 years, incident HF was seen in 10% subjects
(19.4% in those with VPCs vs. 9.4% in those without). The age, race, and gender adjusted hazard
ratio (HR) of HF for VPCs was 1.89 (95% CI = 1.59, 2.24). After multivariable adjustment for
potential confounders, HR (95% CI) of HF for those with any VPC vs. no VPCs was 1.63 (1.36,
1.96). After additional adjustment for incident CHD as a time-varying covariate, the HR (95% CI)
was 1.71 (1.42, 2.08). Presence of higher frequency of VPCs or complex VPCs had similar rates
of HF as compared to single VPC and all were higher than no VPC group. In conclusion, in this
large population based cohort, presence of VPCs is associated with incident HF independent of
incident CHD.
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The occurrence of systolic dysfunction and clinical heart failure (HF) with chronic
tachyarrhythmia though uncommon, has been well described 1. Whether frequent
Ventricular Premature Complexes (VPCs), a common 2, yet mostly asymptomatic ectopic
arrhythmia, are associated with incident HF is unknown. VPCs are associated with
traditional risk factors of coronary heart disease (CHD), a higher incidence of CHD, and
cardiovascular death3-4. Interestingly, those with frequent VPCs have been shown to have a
reduction in ejection fraction 5-6 and poor diastolic function 7. Lastly, a few case reports and
case series have pointed to the existence of VPC-induced cardiomyopathy, including its
reversal with VPC ablation 8-11. This study examined whether the presence of VPCs on a 2-
minute ECG recording is associated with incident HF in a large population based cohort, and
whether this putative association is present independent of incident CHD.
METHODS
The Atherosclerosis Risk in Communities (ARIC) Study enrolled 15,792 subjects aged
45-64 years from four U.S. communities: Forsyth County, NC; the city of Jackson, MS;
seven northwestern suburbs of Minneapolis, MN; and Washington County, MD (1987-89).
African-American residents were over-sampled as part of the area-probability sampling of
Forsyth County, NC, while enrollment at the Jackson, MS site was restricted to African-
American residents. A complete description of the ARIC communities and of the design has
been published (http://www.cscc.unc.edu/aric/) 12. The cohort participated in a baseline visit
and three follow-up exams, as well as annual telephone interviews. At study baseline,
information about socioeconomic indicators, medical history, family history, cardiovascular
risk factors, serum chemistries, ECGs, and medication use was collected.
For the present analysis, participants with prevalent HF (Gothenburg criteria = 3 or intake of
medications (such as digoxin, iv diuretics) for HF13, (n = 1039) 14, or missing information
about incident HF were excluded. In addition, participants with missing values for the 12-
lead ECG or 3-lead 2-minute rhythm strip (n = 74) or those with cardiac rhythm
disturbances such as Wolf-Parkinson-White syndrome, atrial fibrillation/flutter, wandering
atrial pacemaker, supra-ventricular tachycardia, or not-sinus rhythm were excluded (n =
283). Participants with missing or invalid values for key covariates (n = 703) or self
identified their race as neither white nor African-American (n= 48) were excluded. Finally,
those with prevalent or missing CHD at baseline (n = 1120) were also excluded. Some
observations met more than one exclusion criteria. The remaining 13,486 cohort participants
were included in this study analyses.
In subset analyses involving adjustment for LVH using Cornell voltage, those with QRS
duration ≥120 ms (n=542), were additionally excluded thus leaving 12944 participants for
this analysis.
Participants with incident HF were identified using the International Classification of
Diseases Code, Ninth Revision (ICD-9) from hospital discharges (428.x), and from death
certificates (ICD-9 or ICD-10 codes 428 and I50). Incident HF was defined as the first HF
hospitalization with a HF discharge code or HF as the underlying cause of death on a death
certificate (n=68). HF cases were identified from three triennial reexaminations through
1998, annual telephone interviews to identify all hospitalizations, as well as through
community hospital surveillance for hospitalizations, and searches of National Death Index
registry. Cohort follow up for the current analysis ended on 31st December 2005. The
validity of ICD code for diagnosis of HF hospitalization has been found to be acceptable in
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the ARIC HF surveillance study – similar to the use of the Framingham criteria for HF
(Rosamond et al, poster presented at AHA scientific sessions 2009).
Participants were asked to fast for 12 hours and to refrain from smoking and consuming
caffeinated beverages for 4 hours before the examination. A supine 12-lead ECG at rest and
a 2-minute 3-lead (V1, II, and V5) rhythm strip were obtained using the MAC PC10
personal cardiogram (Marquette Electronics, Milwaukee, Wisconsin). Electrocardiographic
data processing, monitoring, and quality control have been described elsewhere 15. Rhythm
strips were classified 3 times by independent trained coders for total supra-ventricular,
ventricular complexes and ventricular runs, bigeminy, trigeminy, and multiform complexes.
Adjudication of disagreements was performed by the ECG center principal investigator or
the coding supervisor. VPCs and heart rate were determined from the rhythm strip.
The primary exposure was presence of any VPCs on the 2-minute rhythm ECG. VPCs seen
on a 2-minute ECG rhythm strip are highly correlated with high frequency VPCs seen on 24
hour recordings 16. VPCs were classified by the frequency of their occurrence on the 2
minute rhythm strip i.e., single VPC; two or more, and complex. Complex VPCs were
defined as presence of consecutive VPCs, multiple morphologies of VPCs, or the presence
of short-coupled VPC on the 2-minute ECG.
A parsimonious set of potential confounders for the relation of VPCs to incident HF was
chosen based on a strong physiologic relation to VPCs3.
The study protocol manuals on the ARIC website provide detailed information about
determination of prevalent CHD (manual 3), hypertension (manual 11), diabetes (manual
10), educational attainment, medication intake history17, and Cornell voltage estimated left
ventricular (LV) mass18 in the ARIC Study19. Similarly, the definition of these covariates
can be found in the variable dictionary at the ARIC Study website19.
Time-to-event for those without incident HF was censored either at death, or at loss to
follow up, or on the December 31, 2005, whichever occurred earlier. Rate of HF by race,
gender and VPC categories were estimated assuming constant rate over time and a Poisson
distribution. Cox regression models were used to estimate the hazard ratio of HF contrasting
the presence of any VPC with no VPC. Finally, multivariable Cox regression models were
fit including interaction terms between main exposure and age categories, race, gender,
diabetes, hypertension, and heart rate (categories at 95th percentile), after adjusting for other
potential confounders associated with prevalent VPCs and HF. Relationships by increasing
frequency or complexity of VPCs were examined using dummy variables for the categories
defined above. Further, to examine the effect of higher frequency of VPCs on HF, we
further classified frequencies as 0, 1, 2 to 4, 5 or greater.
As additional analyses a). Cox model was adjusted for incident CHD as time-varying
covariate, and b). adjustment for left ventricular mass using Cornell voltage was done in a
subset analysis as this required further exclusion of study participants. The proportional
hazard assumption was evaluated both using graphical methods (ln-ln S (t) graphs) and Cox
tests and was not invalidated. Multivariable adjusted cumulative HF curves were plotted by
presence of VPC using inverse probability weights 20.
All statistical computations were performed using SAS software version 9.1.3 (SAS Inc.,
Cary, North Carolina). A p value of < 0.05 for a two-sided null hypothesis was considered
statistically significant for main covariates. A p value of <0.2 was considered statistically
significant for interaction terms.
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At least a single VPC was identified in 739 (5.5%) of the 13,486 study participants using
baseline rhythm strip recorded for 2 minutes duration. The differences in the characteristics
of the study participants by presence of any VPC and by incident HF status are shown in
Table 1.
Incident HF was seen in 10% of subjects during an average (SD) follow up period of 15.6
(3.8) years. Cumulative proportion of Incident HF was higher (19.4%) in those with any
VPCs than those without (9.4%). The unadjusted rate of HF in individuals with any VPCs
was more than twice that of those without (rate /1000 person year = 13.5 vs. 6.0, p<0.001).
The age, race, and gender adjusted hazard ratio (HR) of HF for any VPCs was 1.89 (95% CI
= 1.59, 2.24). After multivariable adjustment for age, gender, race, study center, level of
education, blood glucose level, diabetes, systolic blood pressure, intake of antihypertensive
medications, LDL-cholesterol, HDL-cholesterol, BMI, smoking status, pack-years of
smoking, alcohol intake, heart rate, serum K+, serum Mg++, the HR (95% CI) of HF among
those with any VPC vs. no VPCs was 1.63 (1.36, 1.96). Figure 1 shows the multivariable
adjusted cumulative proportion of HF by presence of any VPCs.
The above results did not change appreciably after additional adjustment for 1) left
ventricular mass using Cornell voltage (HR 1.59, 95% CI 1.32, 1.92) or medications such as
beta blockers, anti-arrhythmic, and calcium channel blockers. Also, the association existed
after adjustment for incident CHD as a time varying covariate (HR 1.71, 95% CI 1.42, 2.08).
The rate of HF was similar in participants with either 1) a higher frequency or 2) complexity
of VPCs when compared to those with single VPC (Figure 2); all of which had higher rates
than those without any VPC. However, when examining the effect of higher frequency as
single, 2-4, 5 or greater, as compared to none the HR (95% CI) were 1.84 (1.41, 2.41), 1.98
(1.49, 2.63), and 2.16 (1.56, 3.00).
Table 2 shows differences in the association of VPC with HF by strata of selected
characteristics. The relationship between VPCs and HF was stronger among whites as
compared to African-Americans. Also, the association between VPC with HF was small and
statistically non significant in those with diabetes. There was no difference in the association
by strata of heart rate.
DISCUSSION
In this large community-based cohort of white and African-American men and women free
of CHD and HF at baseline, we found that VPCs were associated with incident HF. This
relationship was independent of several potential confounders including baseline left
ventricular mass and incident CHD.
There are several pathways including dys-synchronous ventricular contraction, mechanical
bradycardia, tachypacing, and residual confounding due to atherosclerotic burden that can
link VPCs with HF. At a basic electrophysiological level, conditions that cause dys-
synchrony such as permanent or transient bundle branch blocks have a profound effect on
ventricular depolarization and repolarization, affecting action potential durations and leading
to adverse remodeling in ventricular dimensions and function. During and following the
VPCs, changes in heart rate, blood pressure, and stroke volume may occur as a consequence
of changes in ventricular filling, ventricular contractility, and baroreflex activity 21. In those
with frequent PVCs a poorer systolic/diastolic function 57, a greater deterioration in left
ventricular function over time6, and a reversal of cardiomyopathy following their ablation in
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selected patients 11, 22-23 has been reported. Also, responders to cardiac resynchronization
therapy (CRT) had a lower prevalence of VPCs 24 – suggesting a role for VPCs in the
continuing decline in cardiac function. Lastly, VPCs have been linked to a higher incidence
of atrial fibrillation 25 which can precipitate HF 26. Despite several mechanism outlined
above, at present the causes of VPC-induced cardiomyopathy remains poorly understood 27.
Various sources of VPCs have been identified including scar tissue, papillary muscle,
Purkinje network system, mitral annulus, and aortic sinus cusps; however, it seems that most
of the monomorphic and potentially curable VPCs may originate from the ventricular
outflow tract 28. Many studies suggest the role of VPCs originating from the right
ventricular outflow tract in cardiomyopathy 10, 22, 29.
Although a higher VPC frequency did show a trend towards slightly increased risk of HF
risk in our study, the power was limited; in acute settings, a frequency greater than 10% has
been suggested as a good indicator of response to radiofrequency ablation (RFA)23.
Similarly, few of those with single VPCs at baseline may actually have complex VPCs if a
longer recording is done, this might explain the little difference in the association of
complex VPCs with HF as compared to single VPC with HF.
The reasons for lower magnitude of the association between VPCs and HF observed in those
with diabetes than those without, is not clear. Higher rates of competing risk of the fatal and
non-fatal outcomes we studied among diabetics may account for this. Also, differences in
the distribution of unmeasured confounders, differences in the origin/severity of VPCs, or
variation in diagnosis/treatment at the sites where African Americans were studied may
explain some of these differences.
Strengths of the present study include its large sample size, extensive follow-up, and
population-based sampling so that the results can be extrapolated with a greater confidence
to the general population. Limitations including poor sensitivity of 2 minute rhythm strip
(though highly specific)16, and non-availability of serial VPCs evaluation –can cause
regression dilution, thus leading to a bias towards null. Another limitation is that our study’s
definition of HF would likely miss individuals whose HF is successfully managed in
outpatient settings, and those who died before their first hospitalization with HF; this would
be unlikely given the long follow up in the study and high rate of hospitalizations among
patients with HF. Detailed information about HF by echocardiography was not available.
However, positive association despite adjustment for incident CHD does support that the
relationship is not primarily due to ischemic cardiomyopathy. Unmeasured confounders,
although we are not aware of any, may account for some of the association seen in this
study. Lastly, though adjustment for manifest incident CHD was done, residual confounding
by undiagnosed or silent CHD can’t be ruled out. The fact that hazard ratio increased after
adjustment of overt CHD is however reassuring that all of the observed risk is not possibly
explained by higher rate of CHD in those with VPCs.
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Multivariable adjusted cumulative heart failure events during follow up by the presence any
VPCs (143 HF events among 739) vs. absence (1201 HF events among 12747) events in a 2-
minute ECG strip among ARIC cohort participants free of heart failure and coronary heart
disease at study baseline. (Wilcoxon test P<0.001). Model adjusted for age, gender, race,
study center, education level, diabetes, systolic blood pressure, hypertension medication
intake, LDL and HDL cholesterol, BMI, current smoking, former smoking, pack-years of
smoking, amount of ethanol use, heart rate, serum K+, serum Mg++.
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Hazards ratio of Heart Failure by presence of single (n=298), two-or-more (n = 358), and
complex (n = 83) Ventricular premature complexes (VPCs) as compared to no (n = 12747)
VPCs in a cohort of middle aged men and women free of CHD at baseline. Cox proportional
hazards model adjusted for age, gender, race, study center, education level, diabetes, systolic
blood pressure, hypertension medication intake, LDL and HDL cholesterol, BMI, current
smoking, former smoking, pack-years of smoking, amount of ethanol use, heart rate, serum
K+, serum Mg++. Results from the ARIC study (1987 through 2005).
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Table 1
Characteristics of participants by prevalence of VPC at baseline and occurrence of new-onset Heart Failure
during follow up: The Atherosclerosis Risk In Communities Study (1987 to 2005)
Characteristics* Any VPC on 2 minute ECG Heart Failure during follow up
Yes (n= 739) No (n= 12747) Yes (n= 1344) No (n= 12142)
Age (in yrs) 56.0 (5.7) 53.8 (5.7) 56.5 (5.4) 53.7 (5.7)
Women 49.4 56.4 50.6 56.6
African American 29.9 25.8 36.5 24.8
Education
 Less than High School 27.9 21.9 39.9 20.3
 High school but less than college 41.0 41.2 36.8 41.7
 College or more 31.1 36.9 23.4 38.0
Body Mass Index (kg/m*m) 28.2 (5.5) 27.4 (5.2) 29.6 (6.3) 27.2 (5.1)
LDL cholesterol (mg/dl) 136.5 (38.3) 137.1 (39.1) 142.6 (40.2) 136.5 (38.9)
HDL cholesterol (mg/dl) 51.4 (16.6) 52.6 (17.0) 48.1 (15.7) 53.0 (17.0)
Potassium (mmol/L) 4.4 (0.5) 4.4 (0.5) 4.4 (0.5) 4.4 (0.5)
Magnesium (mEq/L) 1.6 (0.2) 1.6 (0.2) 1.6 (0.2) 1.6 (0.2)
Heart rate (beats/min) 68.0 (10.8) 66.4 (10.1) 69.1 (11.5) 66.2 (9.9)
Cornell voltage‡ (mV) 1.3 (0.6) 1.2 (0.5) 1.4 (0.6) 1.2 (0.5)
Systolic BP (mm of Hg) 124.8 (19.0) 120.6 (18.5) 130.6 (21.6) 119.8 (17.9)
Hypertension 41.5% 30.9% 54.0% 29.0%
Anti-hypertensives 29.9% 21.2% 39.6% 19.7%
Glucose 109.5 (40.0) 106.9 (36.8) 130.5 (69.2) 104.4 (30.4)
Diabetes 11.5% 8.1% 25.7% 6.3%
Current smoking 25.2% 25.9% 37.6% 24.5%
Former Smoking 33.6% 31.3% 31.0% 31.5%
Pack-years of smoking 17.3 (23.1) 14.9 (20.6) 22.7 (26.1) 14.2 (19.9)
Alcohol intake (gms/week) 45.9 (118.8) 42.1 (92.1) 38.7 (91.5) 42.7 (94.0)
Any VPCs† 100% 0 10.6% 4.9%
Single 40.3% 0 3.9% 2.0%
More than one VPC 48.4% 0 5.3% 2.4%
Complex VPCs 11.2% 0 1.4% 0.5%
*
Characteristics expressed as percentage of column or means with standard deviation
†
VPC coded by investigators using 2-minute (3-lead ECG strips) at baseline
Cornell voltage was calculated in those with QRS <120 ms, with non-missing values, and not having prevalent CHD.
Complex VPCs were defined by the presence of consecutive, multi-morphic, or short coupled (<5 percentile).
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Table 2
Multivariable adjusted Cox regression model for Heart Failure*: the Atherosclerosis Risk In Communities
Study (1987 through 2005)
Stratum Hazard ratio † 95% CI Interaction P value‡
Overall 1.63 1.37 1.95
Age <55 years 1.80 1.30 2.51 0.29
Age >=55 years 1.60 1.30 1.96
Female 1.44 1.10 1.87 0.02
Male 1.83 1.45 2.32
African American 1.44 1.07 1.93 0.13
White 1.77 1.42 2.20
Diabetes 1.26 0.88 1.82 0.01
No Diabetes 1.83 1.50 2.24
Hypertension 1.62 1.29 2.03 0.46
No Hypertension 1.72 1.30 2.28
Heart rate <85 1.64 1.36 1.98 0.87
Heart rate >=85 1.62 0.99 2.67
*
Incident heart failure cases from study enrollment (1987-89) through 2005
†
Estimates are hazard ratio for presence of any VPC in 2-minute (3-lead ECG strips) at study baseline from multivariable models in each stratum.
With the exception of corresponding row variable, each model was adjusted for age, gender, race, study center, education level, diabetes, systolic
blood pressure, hypertension medication intake, LDL and HDL cholesterol, BMI, current smoking, former smoking, pack-years of smoking,
amount of ethanol use, heart rate, serum K+, serum Mg++. Heart rate of 85 corresponds to the 95th percentile for ARIC study cohort at baseline
visit.
‡
Interaction term includes the exposure variable (presence of any VPCs) and the corresponding row variable; a p value corresponding to this
product term is labeled as interaction p value and a value <0.05 suggests strong statistical interaction.
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